ÂÜÀòÂÒÂ×

With over 30 years of experience in the medical device industry, Dr. Fain was the former Senior Vice President and Group President, Cardiovascular and Neuromodulation at Abbott following their acquisition of St. Jude Medical in 2017. Dr. Fain became Group President of St. Jude Medical in 2014 where his responsibilities included the global sales, marketing, R&D, clinical and regulatory functions across the entire St. Jude Medical portfolio worldwide. Dr. Fain joined St. Jude Medical in 1997 as Vice President, Systems Development as part of the company’s acquisition of Ventritex, Inc., a startup implantable defibrillator company where he had worked since 1987. After holding senior executive positions in Clinical, Regulatory and R&D for the Cardiac Rhythm Management Division (CRMD), he became President, CRMD in 2007 and was named President of the company’s Implantable Electronic Systems Division in 2012 when its CRM/heart failure and neuromodulation divisions merged. Dr. Fain received his M.D. from Stanford University School of Medicine and holds a Sc.B. degree in applied math/biology from Brown University.